These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 27416665

  • 21. Revised Gleason grading system is a better predictor of indolent prostate cancer at the time of diagnosis: retrospective clinical-pathological study on matched biopsy and radical prostatectomy specimens.
    Giunchi F, Brunocilla E, Borghesi M, Rizzi S, Ricci MS, Romagnoli D, Martorana G, Schiavina R, Fiorentino M.
    Clin Genitourin Cancer; 2014 Oct; 12(5):325-9. PubMed ID: 24583160
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of concordance of Gleason score between prostate biopsy and radical prostatectomy.
    Mansouri N, Msakni I, Gargouri F, Khiari R, Bouziani A, Laabidi B.
    Tunis Med; 2018 Jul; 96(7):430-436. PubMed ID: 30430487
    [Abstract] [Full Text] [Related]

  • 23. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
    King CR, McNeal JE, Gill H, Presti JC.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):386-91. PubMed ID: 15145152
    [Abstract] [Full Text] [Related]

  • 24. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L, Poulos CK, Pan CX, Jones TD, Daggy JK, Eble JN, Koch MO.
    J Urol; 2005 Sep 01; 174(3):898-902. PubMed ID: 16093983
    [Abstract] [Full Text] [Related]

  • 25. Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome.
    Pinthus JH, Witkos M, Fleshner NE, Sweet J, Evans A, Jewett MA, Krahn M, Alibhai S, Trachtenberg J.
    J Urol; 2006 Sep 01; 176(3):979-84; discussion 984. PubMed ID: 16890675
    [Abstract] [Full Text] [Related]

  • 26. PI-RADS v2 and periprostatic fat measured on multiparametric magnetic resonance imaging can predict upgrading in radical prostatectomy pathology amongst patients with biopsy Gleason score 3 + 3 prostate cancer.
    Zhai L, Fan Y, Sun S, Wang H, Meng Y, Hu S, Wang X, Yu W, Jin J.
    Scand J Urol; 2018 Sep 01; 52(5-6):333-339. PubMed ID: 30895901
    [Abstract] [Full Text] [Related]

  • 27. [Surgical strategy selection and experience summary of prostate cancer with positive single needle biopsy].
    Hao YC, Yan Y, Zhang F, Qiu M, Zhou L, Liu K, Lu J, Xiao CL, Huang Y, Liu C, Ma LL.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug 18; 52(4):625-631. PubMed ID: 32773790
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Role of prostate health index to predict Gleason score upgrading and high-risk prostate cancer in radical prostatectomy specimens.
    Kim H, Jung G, Kim JH, Byun SS, Hong SK.
    Sci Rep; 2021 Aug 31; 11(1):17447. PubMed ID: 34465825
    [Abstract] [Full Text] [Related]

  • 32. Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: results from the SEARCH database.
    Turley RS, Hamilton RJ, Terris MK, Kane CJ, Aronson WJ, Presti JC, Amling CL, Freedland SJ, SEARCH Database Study Group.
    J Urol; 2008 Feb 31; 179(2):523-7; discussion 527-8. PubMed ID: 18076952
    [Abstract] [Full Text] [Related]

  • 33. Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012.
    Danneman D, Drevin L, Delahunt B, Samaratunga H, Robinson D, Bratt O, Loeb S, Stattin P, Egevad L.
    BJU Int; 2017 Jan 31; 119(1):50-56. PubMed ID: 26918298
    [Abstract] [Full Text] [Related]

  • 34. Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens.
    Lima NG, Soares Dde F, Rhoden EL.
    Clinics (Sao Paulo); 2013 Jun 31; 68(6):820-4. PubMed ID: 23778496
    [Abstract] [Full Text] [Related]

  • 35. Final pathohistology after radical prostatectomy in patients eligible for active surveillance (AS).
    Lellig E, Gratzke C, Kretschmer A, Stief C.
    World J Urol; 2015 Jul 31; 33(7):917-22. PubMed ID: 26047652
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Does the delay from prostate biopsy to radical prostatectomy influence the risk of biochemical recurrence?].
    Meunier ME, Neuzillet Y, Radulescu C, Cherbonnier C, Hervé JM, Rouanne M, Molinié V, Lebret T.
    Prog Urol; 2018 Sep 31; 28(10):475-481. PubMed ID: 29907495
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.